Associate Professor Dr Tim Clay was awarded the Best New Concept at the 2021 AGITG Annual Scientific Meeting for his concept ‘The ACE study’, which is investigating amivantamab activity in colorectal carcinoma previously treated with an EGFR monoclonal antibody.
